SEC Filings

SEC Filings

Filing date Description Form View

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001104659-23-099802.pdf
0001104659-23-099802.rtf
0001104659-23-099802.xls

Report of unscheduled material events or corporate event

 8-K View HTML
0001104659-23-103175.pdf
0001104659-23-103175.rtf
0001104659-23-103175.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001104659-23-104363.pdf
0001104659-23-104363.rtf
0001104659-23-104363.xls

CORRESP

 CORRESP View HTML
0001104659-23-104570.pdf
0001104659-23-104570.rtf
0001104659-23-104570.xls

EFFECT

 EFFECT View HTML
9999999995-23-002883.pdf
9999999995-23-002883.rtf
9999999995-23-002883.xls

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

 424B4 View HTML
0001104659-23-106172.pdf
0001104659-23-106172.rtf
0001104659-23-106172.xls

Report of unscheduled material events or corporate event

 8-K View HTML
0001104659-23-107164.pdf
0001104659-23-107164.rtf
0001104659-23-107164.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Report of unscheduled material events or corporate event

 8-K View HTML
0001104659-23-109130.pdf
0001104659-23-109130.rtf
0001104659-23-109130.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Statement of changes in beneficial ownership of securities

 4 View HTML
0001235802-23-000110.pdf
0001235802-23-000110.rtf
0001235802-23-000110.xls

Report of unscheduled material events or corporate event

 8-K View HTML
0001558370-23-018328.pdf
0001558370-23-018328.rtf
0001558370-23-018328.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Displaying 1341 - 1350 of 1362 results

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE